Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 018891

Expand all

CATAPRES-TTS-1 (CLONIDINE)
0.1MG/24HR
Marketing Status: Prescription

Active Ingredient: CLONIDINE
Proprietary Name: CATAPRES-TTS-1
Dosage Form; Route of Administration: SYSTEM; TRANSDERMAL
Strength: 0.1MG/24HR
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N018891
Product Number: 001
Approval Date: Oct 10, 1984
Applicant Holder Full Name: LAVIPHARM SA
Marketing Status:  Prescription
Patent and Exclusivity Information

CATAPRES-TTS-2 (CLONIDINE)
0.2MG/24HR
Marketing Status: Prescription

Active Ingredient: CLONIDINE
Proprietary Name: CATAPRES-TTS-2
Dosage Form; Route of Administration: SYSTEM; TRANSDERMAL
Strength: 0.2MG/24HR
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N018891
Product Number: 002
Approval Date: Oct 10, 1984
Applicant Holder Full Name: LAVIPHARM SA
Marketing Status:  Prescription
Patent and Exclusivity Information

CATAPRES-TTS-3 (CLONIDINE)
0.3MG/24HR
Marketing Status: Prescription

Active Ingredient: CLONIDINE
Proprietary Name: CATAPRES-TTS-3
Dosage Form; Route of Administration: SYSTEM; TRANSDERMAL
Strength: 0.3MG/24HR
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N018891
Product Number: 003
Approval Date: Oct 10, 1984
Applicant Holder Full Name: LAVIPHARM SA
Marketing Status:  Prescription
Patent and Exclusivity Information